1. Home
  2. XRTX vs EDBL Comparison

XRTX vs EDBL Comparison

Compare XRTX & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • EDBL
  • Stock Information
  • Founded
  • XRTX 2011
  • EDBL 2020
  • Country
  • XRTX Canada
  • EDBL United States
  • Employees
  • XRTX N/A
  • EDBL N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • EDBL Farming/Seeds/Milling
  • Sector
  • XRTX Health Care
  • EDBL Consumer Staples
  • Exchange
  • XRTX Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • XRTX 3.0M
  • EDBL 2.9M
  • IPO Year
  • XRTX N/A
  • EDBL 2022
  • Fundamental
  • Price
  • XRTX $1.08
  • EDBL $1.93
  • Analyst Decision
  • XRTX
  • EDBL
  • Analyst Count
  • XRTX 0
  • EDBL 0
  • Target Price
  • XRTX N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • XRTX 44.3K
  • EDBL 70.2K
  • Earning Date
  • XRTX 05-16-2025
  • EDBL 05-14-2025
  • Dividend Yield
  • XRTX N/A
  • EDBL N/A
  • EPS Growth
  • XRTX N/A
  • EDBL N/A
  • EPS
  • XRTX N/A
  • EDBL N/A
  • Revenue
  • XRTX N/A
  • EDBL $13,857,000.00
  • Revenue This Year
  • XRTX N/A
  • EDBL $29.56
  • Revenue Next Year
  • XRTX N/A
  • EDBL $20.00
  • P/E Ratio
  • XRTX N/A
  • EDBL N/A
  • Revenue Growth
  • XRTX N/A
  • EDBL N/A
  • 52 Week Low
  • XRTX $0.80
  • EDBL $1.82
  • 52 Week High
  • XRTX $3.24
  • EDBL $230.00
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 59.65
  • EDBL 37.66
  • Support Level
  • XRTX $0.82
  • EDBL $1.82
  • Resistance Level
  • XRTX $1.13
  • EDBL $2.12
  • Average True Range (ATR)
  • XRTX 0.10
  • EDBL 0.18
  • MACD
  • XRTX 0.03
  • EDBL 0.04
  • Stochastic Oscillator
  • XRTX 71.65
  • EDBL 20.87

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: